scholarly journals Cross-site transportability of an explainable artificial intelligence model for acute kidney injury prediction

2020 ◽  
Vol 11 (1) ◽  
Author(s):  
Xing Song ◽  
Alan S. L. Yu ◽  
John A. Kellum ◽  
Lemuel R. Waitman ◽  
Michael E. Matheny ◽  
...  

Abstract Artificial intelligence (AI) has demonstrated promise in predicting acute kidney injury (AKI), however, clinical adoption of these models requires interpretability and transportability. Non-interoperable data across hospitals is a major barrier to model transportability. Here, we leverage the US PCORnet platform to develop an AKI prediction model and assess its transportability across six independent health systems. Our work demonstrates that cross-site performance deterioration is likely and reveals heterogeneity of risk factors across populations to be the cause. Therefore, no matter how accurate an AI model is trained at the source hospital, whether it can be adopted at target hospitals is an unanswered question. To fill the research gap, we derive a method to predict the transportability of AI models which can accelerate the adaptation process of external AI models in hospitals.

2019 ◽  
Vol 35 (2) ◽  
pp. 204-205 ◽  
Author(s):  
Wim Van Biesen ◽  
Jill Vanmassenhove ◽  
Johan Decruyenaere

Critical Care ◽  
2016 ◽  
Vol 20 (1) ◽  
Author(s):  
Jochen Metzger ◽  
William Mullen ◽  
Holger Husi ◽  
Angelique Stalmach ◽  
Stefan Herget-Rosenthal ◽  
...  

2007 ◽  
Vol 72 (5) ◽  
pp. 624-631 ◽  
Author(s):  
H. Palomba ◽  
I. de Castro ◽  
A.L.C. Neto ◽  
S. Lage ◽  
L. Yu

2016 ◽  
Vol 43 (4) ◽  
pp. 261-270 ◽  
Author(s):  
Jeremiah R. Brown ◽  
Michael E. Rezaee ◽  
William M. Hisey ◽  
Kevin C. Cox ◽  
Michael E. Matheny ◽  
...  

Background: Dialysis-requiring acute kidney injury (AKI-D) is a documented complication of hospitalization and procedures. Temporal incidence of AKI-D and related hospital mortality in the US population has not been recently characterized. We describe the epidemiology of AKI-D as well as associated in-hospital mortality in the US. Methods: Retrospective cohort of a national discharge data (n = 86,949,550) from the Healthcare Cost and Utilization Project's National Inpatient Sample, 2001-2011 of patients' hospitalization with AKI-D. Primary outcomes were AKI-D and in-hospital mortality. We determined the annual incidence rate of AKI-D in the US from 2001 to 2011. We estimated ORs for AKI-D and in-hospital mortality for each successive year compared to 2001 using multiple logistic regression models, adjusted for patient and hospital characteristics, and stratified the analyses by sex and age. We also calculated population-attributable risk of in-hospital mortality associated with AKI-D. Results: The adjusted odds of AKI-D increased by a factor of 1.03 (95% CI 1.02-1.04) each year. The number of AKI-D-related (19,886-34,195) in-hospital deaths increased almost 2-fold, although in-hospital mortality associated with AKI-D (28.0-19.7%) declined significantly from 2001 to 2011. Over the same period, the adjusted odds of mortality for AKI-D patients were 0.60 (95% CI 0.56-0.67). Population-attributable risk of mortality associated with AKI-D increased (2.1-4.2%) over the study period. Conclusions: The incidence rate of AKI-D has increased considerably in the US since 2001. However, in-hospital mortality associated with AKI-D hospital admissions has decreased significantly.


Sign in / Sign up

Export Citation Format

Share Document